S. Marin

791 total citations
20 papers, 665 citations indexed

About

S. Marin is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, S. Marin has authored 20 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 11 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in S. Marin's work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (4 papers). S. Marin is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (4 papers). S. Marin collaborates with scholars based in Finland. S. Marin's co-authors include E. Alhava, Karí Syrjänen, Matti Eskelinen, P. Lipponen, S. Aaltomaa, Veli‐Matti Kosma, P Lipponen, V-M Kosma, M Eskelinen and Kimmo Mäkinen and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

S. Marin

20 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Marin Finland 13 422 217 150 141 116 20 665
Nobue Kumaki Japan 14 300 0.7× 201 0.9× 86 0.6× 135 1.0× 109 0.9× 47 600
Marie Ludvíková Czechia 17 227 0.5× 346 1.6× 52 0.3× 323 2.3× 214 1.8× 54 901
Lars Tharun Germany 15 434 1.0× 179 0.8× 118 0.8× 471 3.3× 140 1.2× 41 966
Sanne Kjær‐Frifeldt Denmark 12 304 0.7× 168 0.8× 37 0.2× 154 1.1× 71 0.6× 22 520
I Ruschenburg Germany 13 187 0.4× 79 0.4× 49 0.3× 186 1.3× 90 0.8× 41 464
Billie‐Jo M. Kerns United States 12 338 0.8× 185 0.9× 60 0.4× 228 1.6× 35 0.3× 18 592
Annette Affolter Germany 16 368 0.9× 104 0.5× 91 0.6× 389 2.8× 104 0.9× 43 716
Yoshika Nagata Japan 18 356 0.8× 102 0.5× 220 1.5× 146 1.0× 65 0.6× 45 706
Soong June Bae South Korea 15 347 0.8× 273 1.3× 89 0.6× 85 0.6× 133 1.1× 84 645
T Hietanen Finland 10 416 1.0× 521 2.4× 47 0.3× 158 1.1× 71 0.6× 22 825

Countries citing papers authored by S. Marin

Since Specialization
Citations

This map shows the geographic impact of S. Marin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Marin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Marin more than expected).

Fields of papers citing papers by S. Marin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Marin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Marin. The network helps show where S. Marin may publish in the future.

Co-authorship network of co-authors of S. Marin

This figure shows the co-authorship network connecting the top 25 collaborators of S. Marin. A scholar is included among the top collaborators of S. Marin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Marin. S. Marin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirvikoski, Pasi, E. Kumpulainen, Jukka Virtaniemi, et al.. (1997). p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma.. Journal of Clinical Oncology. 15(9). 3111–3120. 62 indexed citations
2.
Perkkiö, Mikko, Tero Tikanoja, & S. Marin. (1997). Leukemic Coronary Artery Occlusion in a Child with Acute Lymphoblastic Leukemia. Pediatric Cardiology. 18(1). 64–65. 6 indexed citations
3.
Kosma, V-M, et al.. (1996). Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. British Journal of Cancer. 74(5). 766–772. 79 indexed citations
4.
Jantunen, Esa, et al.. (1996). Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies.. PubMed. 23(4). 779–81. 23 indexed citations
5.
Aaltomaa, S., P Lipponen, Veli‐Matti Kosma, et al.. (1993). Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer. The American Journal of Surgery. 165(3). 307–311. 7 indexed citations
6.
Aaltomaa, S., P Lipponen, M Eskelinen, et al.. (1993). Predictive Value of a Morphometric Prognostic Index in Female Breast Cancer. Oncology. 50(1). 57–62. 12 indexed citations
7.
Aaltomaa, S., P Lipponen, M Eskelinen, et al.. (1992). Tumor Size, Nuclear Morphometry, Mitotic Indices as Prognostic Factors in Axillary -Lymph-Node-Positive Breast Cancer. European Surgical Research. 24(3). 160–168. 13 indexed citations
8.
Lipponen, P., S. Aaltomaa, Matti Eskelinen, et al.. (1992). The changing importance of prognostic factors in breast cancer during long‐term follow‐up. International Journal of Cancer. 51(5). 698–702. 17 indexed citations
9.
Lipponen, P, et al.. (1992). Mitotic indexes as prognostic predictors in female breast cancer. Journal of Cancer Research and Clinical Oncology. 118(1). 75–81. 43 indexed citations
10.
Aaltomaa, S., P. Lipponen, Matti Eskelinen, et al.. (1992). Lymphocyte infiltrates as a prognostic variable in female breast cancer. European Journal of Cancer. 28(4-5). 859–864. 233 indexed citations
11.
Eskelinen, Matti, P. Lipponen, S. Marin, et al.. (1992). DNA Ploidy, S-Phase Fraction, and G2 Fraction as Prognostic Determinants in Human Pancreatic Cancer. Scandinavian Journal of Gastroenterology. 27(1). 39–43. 25 indexed citations
12.
Lipponen, P., et al.. (1992). Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.. PubMed. 12(3). 677–82. 9 indexed citations
13.
Aaltomaa, S., P Lipponen, P. Klemi, et al.. (1992). Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.. PubMed. 158(3). 135–41. 16 indexed citations
14.
Aaltomaa, S., P Lipponen, M Eskelinen, et al.. (1992). The significance of nuclear morphometric variables as prognostic predictors in breast cancer.. PubMed. 11(4). 1663–9. 12 indexed citations
15.
Aaltomaa, S., P. Lipponen, M Eskelinen, et al.. (1992). Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.. PubMed. 11(5). 1701–6. 2 indexed citations
16.
Aaltomaa, S., P Lipponen, M Eskelinen, et al.. (1992). Prediction of outcome after first recurrence of breast cancer.. PubMed. 158(1). 13–8. 6 indexed citations
17.
Eskelinen, Matti, P. Lipponen, S. Marin, et al.. (1991). Prognostic Factors in Human Pancreatic Cancer, with Special Reference to Quantitative Histology. Scandinavian Journal of Gastroenterology. 26(5). 483–490. 24 indexed citations
18.
Aaltomaa, S., P. Lipponen, Matti Eskelinen, et al.. (1991). Prognostic factors in axillary lymph node-negative (pN−) breast carcinomas. European Journal of Cancer and Clinical Oncology. 27(12). 1555–1559. 18 indexed citations
19.
Lipponen, P, et al.. (1991). Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer. International Journal of Cancer. 49(6). 886–892. 41 indexed citations
20.
Lipponen, P., Matti Eskelinen, Yrjö Collan, S. Marin, & E. Alhava. (1990). Volume-Corrected Mitotic Index in Human Pancreatic Cancer: Relation to Histologic Grade, Clinical Stage, and Prognosis. Scandinavian Journal of Gastroenterology. 25(6). 548–554. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobue Kumaki Breakdown of academic impact, for papers by Marie Ludvíková Breakdown of academic impact, for papers by Lars Tharun Breakdown of academic impact, for papers by Sanne Kjær‐Frifeldt Breakdown of academic impact, for papers by I Ruschenburg Breakdown of academic impact, for papers by Billie‐Jo M. Kerns Breakdown of academic impact, for papers by Annette Affolter Breakdown of academic impact, for papers by Yoshika Nagata Breakdown of academic impact, for papers by Soong June Bae Breakdown of academic impact, for papers by T Hietanen
Rankless by CCL
2026